Fortress Biotech
(NASDAQ) FBIO
Fortress Biotech Financials at a Glance
Market Cap
$86.60M
Revenue (TTM)
$63.25M
Net Income (TTM)
$31.63M
EPS (TTM)
$-0.27
P/E Ratio
-10.42
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$2.50
Volume
620,168.342
Open
$2.75
Price
$2.50
Volume
620,168.342
Open
$2.75
Previous Close
$2.47
Daily Range
$2.47 - $2.90
52-Week Range
$1.32 - $4.53
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$2.50
Volume
620,168.342
Open
$2.75
Previous Close
$2.47
Daily Range
$2.47 - $2.90
52-Week Range
$1.32 - $4.53
FBIO News
Coronado Biosciences Names New CEO
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Lindsay Allan Rosenwald, MD
Website
www.fortressbiotech.comHeadquarters
Bay Harbor Islands, FL 33154, US
FBIO Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-1%
Net Income Margin
-50%
Return on Equity
10%
Return on Capital
-52%
Return on Assets
-17%
Earnings Yield
-9.60%
Dividend Yield
0.00%
Payout Ratio
-2.62%
Stock Overview
Market Cap
$86.60M
Shares Outstanding
31.04M
Volume
620.17K
Short Interest
0.00%
Avg. Volume
1.01M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$70.22M
EBITDA
$70.22M
Operating Cash Flow
$0.00
Capital Expenditure
$0.00
Free Cash Flow
$0.00
Cash & ST Invst.
$79.38M
Total Debt
$67.22M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.07M
+6.3%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$86.60M
N/A
Market Cap/Employee
$857.38K
N/A
Employees
101
N/A
Net Income
$42.38M
-526.5%
EBITDA
$4.62M
+78.8%
Quarterly Fundamentals
Net Cash
$12.16M
+165.1%
Accounts Receivable
$29.78M
+186.3%
Inventory
$9.62M
-33.3%
Long Term Debt
$65.09M
-10.5%
Short Term Debt
$2.13M
-34.5%
Return on Assets
-17.05%
N/A
Return on Invested Capital
-51.71%
N/A
Free Cash Flow
$47.12M
-265.1%
Operating Cash Flow
$47.12M
-265.1%